4XDL
Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with a brominated fluoxetine derivative.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I24 |
| Synchrotron site | Diamond |
| Beamline | I24 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2013-01-26 |
| Detector | PSI PILATUS 6M |
| Wavelength(s) | 0.8856 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 101.710, 109.840, 166.740 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 35.000 - 3.500 |
| R-factor | 0.2366 |
| Rwork | 0.235 |
| R-free | 0.26330 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4xdj |
| RMSD bond length | 0.009 |
| RMSD bond angle | 0.930 |
| Data reduction software | xia2 |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.10.1) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 39.070 | 3.590 |
| High resolution limit [Å] | 3.500 | 3.500 |
| Rmerge | 0.092 | 1.846 |
| Number of reflections | 24216 | |
| <I/σ(I)> | 17.5 | 1.5 |
| Completeness [%] | 99.9 | 100 |
| Redundancy | 11.4 | 11.2 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 277 | 0.2M KCl, 0.1M MES pH 6.5, 0.05M magnesium chloride, 0.001M cadmium chloride, 18% (v/v) PEG500 Dimethylether |
